Synthetic Opioid key responses
- Mapping evidence-based key responses to synthetic opioids and their implementation strategies
- Field-tested Toolkit with seven implementation guides
Progress report on HIV, viral hepatitis and sexually transmitted infections, 2019 Accountability for the global health sector strategies, 2016–2021
WHO is accountable for reporting back to the World Health Assembly on progress in implementing the strategies based on data received from countries. This report assesses the mid-term progress in 2019 in implementing these global health sector strategies from 2016 to 2021.
Hepatitis C: New Models of Care for Drug Services
This collection of case studies was commissioned by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA contract CT.17.HEA.0088.1.0) to promote the dissemination of good implementation practices in the field of hepatitis C testing and care for people who inject drugs.
WHO Hepatitis C Fact Sheet
WHO fact sheet provides the most recent information about HCV prevention, treatment and testing
Treatment Action Group: Pipeline Report HCV Diagnostics
This report provides an overview of HCV diagnostic screening products and point of care testing developments worldwide.
Treatment Action Group: Pipeline Report HCV Treatments
This report provides an overview of HCV treatment developments worldwide. With information about when new medications will be available.
Treatment Action Group: Hepatitis Fact Sheets
TAG prepared a wonderful collection of hepatitis fact sheets from testing to medications.
Hep C Coalition: Fact Sheets for Compreensive HCV Services for People Who Use Drugs
This fact sheet helps advocates to demand from their governments a comprehensive hepatitis C package of services for people who use and inject drugs. Noting the political realities that certain provisions may not be available in some countries, we strive to see all these services, based on decades of public health evidence, implemented together.
EASL Recommendations on Treatment of Hepatitis C 2018
The European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C describe the optimal management of patients with acute and chronic HCV infections in 2018 and onwards.
ECDC Technical Report Hepatitis B and C testing activities, needs, and priorities in the EU/EEA
The purpose of this work was to provide a baseline situation assessment to inform the guidance development process, and to assess the availability and feasibility of collecting additional morbidity and mortality data from EU/EEA Member States.
Public Health Guidance on HIV, HBV and HCV Testing in the EU/EEA
To support Member States in their efforts to improve case detection and uptake of testing programmes as part of the global effort to eliminate viral hepatitis and HIV as public health threats by 2030, ECDC is providing this evidence-based guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV.
